Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2005-10-04
2005-10-04
Jiang, Shaojia Anna (Department: 1617)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C514S009100, C514S613000
Reexamination Certificate
active
06951841
ABSTRACT:
Pharmaceutical compositions for oral administration comprising a cyclosporin or macrolide as active ingredient, and a polyethoxylated saturated hydroxy-fatty acid.
REFERENCES:
patent: 3288824 (1966-11-01), Mahler et al.
patent: 3813345 (1974-05-01), Urton
patent: 3954967 (1976-05-01), Urton
patent: 4073943 (1978-02-01), Wretlind et al.
patent: 4146499 (1979-03-01), Rosano
patent: 4156719 (1979-05-01), Sezaki et al.
patent: 4388307 (1983-06-01), Cavanak
patent: 4567161 (1986-01-01), Posanski et al.
patent: 4695450 (1987-09-01), Bauer et al.
patent: 4719239 (1988-01-01), Muller et al.
patent: 4794000 (1988-12-01), Ecanow
patent: 4797272 (1989-01-01), Linn et al.
patent: 4797273 (1989-01-01), Linn et al.
patent: 4798823 (1989-01-01), Witzel
patent: 4835002 (1989-05-01), Wolf et al.
patent: 4888239 (1989-12-01), Brox
patent: 4914188 (1990-04-01), Dumont et al.
patent: 4963367 (1990-10-01), Ecanow
patent: 4990337 (1991-02-01), Kurihara et al.
patent: 4996193 (1991-02-01), Hewitt et al.
patent: 5037653 (1991-08-01), Dawson
patent: 5047396 (1991-09-01), Orban et al.
patent: 5154754 (1992-10-01), Damo et al.
patent: 5177110 (1993-01-01), Oechslein et al.
patent: 5206219 (1993-04-01), Desai
patent: 5260301 (1993-11-01), Nakanishi et al.
patent: 5338761 (1994-08-01), Nakajima et al.
patent: 5342625 (1994-08-01), Hauer et al.
patent: 5525590 (1996-06-01), Bollinger et al.
patent: 5639724 (1997-06-01), Cavanak
patent: 5756450 (1998-05-01), Hahn et al.
patent: 5759997 (1998-06-01), Cavanak
patent: 895724 (1983-07-01), None
patent: 1209361 (1986-08-01), None
patent: 641356 (1984-02-01), None
patent: 3316805 (1984-11-01), None
patent: 3924207 (1990-01-01), None
patent: 4418115 (1994-12-01), None
patent: 135171 (1985-03-01), None
patent: 170623 (1986-02-01), None
patent: 211258 (1987-02-01), None
patent: 258856 (1988-02-01), None
patent: 274431 (1988-07-01), None
patent: 314689 (1989-05-01), None
patent: 315 079 (1989-05-01), None
patent: 361928 (1990-04-01), None
patent: 0589843 (1994-03-01), None
patent: 705601 (1996-04-01), None
patent: 2553661 (1985-04-01), None
patent: 2642650 (1990-08-01), None
patent: 2678169 (1992-12-01), None
patent: 1171125 (1969-11-01), None
patent: 2098865 (1982-12-01), None
patent: 2206119 (1988-12-01), None
patent: 2209671 (1989-05-01), None
patent: 2211408 (1989-07-01), None
patent: 2211848 (1989-07-01), None
patent: 2218334 (1989-11-01), None
patent: 2221157 (1990-01-01), None
patent: 2222770 (1990-03-01), None
patent: 2224206 (1990-05-01), None
patent: 2228198 (1990-08-01), None
patent: 2230440 (1990-10-01), None
patent: 024776 (1985-04-01), None
patent: 249918 (1986-07-01), None
patent: 61280435 (1986-12-01), None
patent: 86/02264 (1986-04-01), None
patent: 87/01035 (1987-02-01), None
patent: 88/00059 (1988-01-01), None
patent: 90/08537 (1990-08-01), None
patent: WO 9112008 (1991-08-01), None
patent: 93/20833 (1993-10-01), None
patent: WO 9522982 (1995-08-01), None
patent: WO 9614079 (1996-05-01), None
Board, P.G., FEBS Lett., vol. 315, No. 3, 298-300 (1993).
Carrigan et al., J. Pharm. Sci., 1973, vol. 62, pp. 1476-1479.
Cavanak and Suker, Prog. Allergy vol. 38:65-72 (1986).
Anon., Research Disclosure 21143 (Nov. 1981), p. 420.
Beyer, et al., Pharmazie in unserer Zeit, vol. 12(2):55-60 (1983).
Bhargava, et al., Pharmaceutical Technology, 46-54, Mar. 1987.
Coon, et al., Cancer Res., vol. 51, No. 3, 897-902 (1991).
Chem. Abstr., 95:225610K, Anon. (1981).
Derwent Abst. 84/069426/12 (1984).
Derwent Abst. 92/235, 168/29 (1989).
Derwent Abst 92/216, 793/26 (1990).
Ekman, S., Lipids 22: 657-663 (1987).
Frazer, et al., J. Physiol. (1944) vol. 103, pp. 306-316.
Froemming, et al., Acta Pharm, Technol., vol. 36, No. 4, 214-220 (1990).
Hahn, Biodegradeble Tensides, 1-196, Basel University, Switzerland (1988) (Translation).
Jayakrishnan, et al., J. Soc. Cosmet, Chem. 34:335-350 (1983).
The Merck Index, 9th Ed., Merck & Co., Inc., Rahway, N.J. p. 1017 (1976).
Kraus, et al., Acta Pharm. Technol., vol. 36, No. 4, 221-225 (1990).
Mizushima, 86-335,072/51 (Apr. 26, 1985) (Derwent Abstr).
Mubarak, Development and Testing of New Microemulsions, 1-51 (1982) (Translation).
Muller, et al., Pharm. Ind. 50(11), 1305-1306 (1988).
Muller, et al., Pharm. Ind. 50(3): 370-375 (1988).
Pohler, Micro-Emulsion Gels Structural Investigations and Galenical Properties, 1-100 (1983) (Translation).
Remington's Pharmaceutical Sciences (17th ed.). Microemulsions, Chapter 20, pp. 293-300 (1985).
Reymond, In Vitro In Vivo Model for the Absorption of Cyclosporin A (1986) (Translation).
Reymond and Sucker, Pharmaceutical Research, vol. 5(10): 673-679 (1988).
Reymond et al., Pharmaceutical Research, vol. 5(10):677-679 (1988).
Ritschel, et al., Pharmaceutical Research vol. 5(10): PD 943: S-108 (1988).
Ritschel, et al., Methods and Findings in Experimental and Clinical Pharmacology, vol. 11(4):281-87 (1989).
Ritschel, et al., Methods and Findings in Experimental and Clinical Pharmacology, vol. 12, pp. 127-134 (1990).
W.A. Ritschel, Methods and Findings in Experimental and Clinical Pharmacology, vol. 13, pp. 205-220 (1991).
Takada, 87-024,776/04 (Apr. 4, 1985) (Derwent Abstr.).
Takada, et al., J. Pharmacobio-Dyn. vol. 8: 320-323 (1985).
Takada, et al., J. Pharmaceutical Research vol. 3(1): 48-51 (1986).
Takada, et al., J. Pharmacobio-Dyn. vol. 9: 156-160 (1986).
Takada, et al., J. Pharmacobio-Dyn. vol. 11:80-87 (1988).
Takada, et al., Intern'l Jour. of Pharmaceutics, vol. 44: 107-116 (1988).
Tarr, et al., Pharmaceutical Research, vol. 6(1): 40-43 (1989).
Yanagawa, et al., J. Microancapsulation 6(2): 161-164 (1989).
Ziegenmeyer, et al., Acta Pharmaceutical Technologica, vol. 26(4): 273-275 (1980).
Neuer Klaus
Petszulat Monika
Walch Hatto
Hess Susan
Jiang Shaojia Anna
Novartis AG
LandOfFree
Pharmaceutical compositions of macrolides or cyclosporine... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pharmaceutical compositions of macrolides or cyclosporine..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutical compositions of macrolides or cyclosporine... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3441661